Johnson & Johnson Uncategorized Contracts & Agreements

31 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Intellectual Property Agreement, dated as of May 3, 2023, by and between Johnson & Johnson and Kenvue Inc
Johnson & Johnson
Pharmaceuticals
DE
2023
Employee Matters Agreement, dated as of May 3, 2023, by and between Johnson & Johnson and Kenvue Inc
Johnson & Johnson
Pharmaceuticals
DE
2023
Tax Matters Agreement, dated as of May 3, 2023, by and between Johnson & Johnson and Kenvue Inc
Johnson & Johnson
Pharmaceuticals
DE
2023
The Johnson & Johnson Excess Savings Plan (amended and restated as of January 1, 2022) Filed with this document
Johnson & Johnson
Pharmaceuticals
2023
Exhibit 10(a)
Johnson & Johnson
Pharmaceuticals
2019
JOHNSON & JOHNSON COMPANY ORDER
Johnson & Johnson
Pharmaceuticals
2017
[Signatures on the Next Page]
Johnson & Johnson
Pharmaceuticals
NY
2017
JOHNSON & JOHNSON 1.650%NOTE DUE 2035
Johnson & Johnson
Pharmaceuticals
NJ
2016
JOHNSON & JOHNSON 1.150%NOTE DUE 2028
Johnson & Johnson
Pharmaceuticals
NJ
2016
JOHNSON & JOHNSON 0.650%NOTE DUE 2024
Johnson & Johnson
Pharmaceuticals
NJ
2016
PRINCIPAL AMOUNT
Johnson & Johnson
Pharmaceuticals
NJ
2016
JOHNSON & JOHNSON COMPANY ORDER
Johnson & Johnson
Pharmaceuticals
2016
JOHNSON & JOHNSON COMPANY ORDER
Johnson & Johnson
Pharmaceuticals
2016
CERTIFICATION OF AMENDMENTS TO THE EXCESS BENEFIT PLAN OF JOHNSON & JOHNSON AND AFFILIATED COMPANIES
Johnson & Johnson
Pharmaceuticals
2015
JOHNSON & JOHNSON COMPANY ORDER
Johnson & Johnson
Pharmaceuticals
2014
JOHNSON & JOHNSON COMPANY ORDER
Johnson & Johnson
Pharmaceuticals
2013
Peter M. FasoloVice President, Global Human ResourcesOne Johnson & Johnson PlazaExecutive Committee MemberNew Brunswick, NJ 08933September 27, 2012
Johnson & Johnson
Pharmaceuticals
2012
THE JOHNSON & JOHNSON EXECUTIVE INCOME DEFERRAL PLAN Amended and Restated Effective January 1, 2010
Johnson & Johnson
Pharmaceuticals
2012
JPMorgan Chase Bank, National Association P.O. Box 161 60 Victoria Embankment London EC4Y 0JP England
Johnson & Johnson
Pharmaceuticals
NY
2012
Goldman, Sachs & Co. 200 West Street New York, New York 10282-2198
Johnson & Johnson
Pharmaceuticals
NY
2012
JOHNSON & JOHNSON AMENDED AND RESTATED DEFERRED FEE PLAN FOR DIRECTORS (Amended as of January 17, 2012)
Johnson & Johnson
Pharmaceuticals
NJ
2012
EX-101 INSTANCE DOCUMENT
Johnson & Johnson
Pharmaceuticals
2011
EX-101 INSTANCE DOCUMENT
Johnson & Johnson
Pharmaceuticals
2010
JOHNSON & JOHNSON COMPANY ORDER
Johnson & Johnson
Pharmaceuticals
2010
EX-101 INSTANCE DOCUMENT
Johnson & Johnson
Pharmaceuticals
2010
EX-101 INSTANCE DOCUMENT
Johnson & Johnson
Pharmaceuticals
NJ
2009
EX-10.R: AMENDMENTS TO THE EXCESS BENEFIT PLAN
Johnson & Johnson
Pharmaceuticals
2009
EX-10.P: AMENDMENTS TO THE JOHNSON & JOHNSON EXCESS SAVINGS PLAN
Johnson & Johnson
Pharmaceuticals
2009
EX-10.N: AMENDMENTS TO THE EXECUTIVE INCOME DEFERRAL PLAN
Johnson & Johnson
Pharmaceuticals
2009
EX-10.L: AMENDMENTS TO THE DEFERRED FEE PLAN FOR DIRECTORS
Johnson & Johnson
Pharmaceuticals
2009
Form of Affiliate Letter
Johnson & Johnson
Pharmaceuticals
2006